(Q48591929)

English

Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.

scientific article published in May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

1 reference

based on heuristic

inferred from title

premenstrual syndrome

1 reference

based on heuristic

inferred from title

Inger Sundström-Poromaa

object named as

Inger Sundström Poromaa

5

0 references

Torbjörn C. Bäckström

2

object named as

Torbjörn Bäckström

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

author name string

Sigrid Nyberg

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

Elisabeth Zingmark

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

Robert H Purdy

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

Gynecological Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

23

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

257-266

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

Successful Treatment of Severe Premenstrual Syndrome by Combined Use of Gonadotropin-Releasing Hormone Agonist and Estrogen/Progestin*

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Progesterone metabolite allopregnanolone in women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Allopregnanolone concentrations and premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Allopregnanolone levels and symptom improvement in severe premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Allopregnanolone and pregnanolone are produced by the human corpus luteum

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Tolerance development to Morris water maze test impairments induced by acute allopregnanolone.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

The role of hormones and hormonal treatments in premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Pregnanolone emulsion. A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Pathogenesis in menstrual cycle-linked CNS disorders

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Severe behavioral complications following intracarotid sodium amobarbital injection: implications for hemispheric asymmetry of emotion

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Effects of response requirement and alcohol on human aggressive responding

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Emotional outbursts and post-traumatic stress disorder during intracarotid amobarbital procedure.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

The effects of diazepam (valium) and aggressive disposition on human aggression: an experimental investigation

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Central-nervous side effects of midazolam during transesophageal echocardiography

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Neurosteroids, GABAA receptors, and escalated aggressive behavior

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Progesterone effects during sequential hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Mood stabilizer combinations for bipolar disorder.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Potentiation of placebo analgesia by proglumide

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

The placebo effect on mood and behavior: the role of the endogenous opioid system

1 reference

https://api.crossref.org/works/10.1080%2F09513590701253511

21 January 2018

Identifiers

10.1080/09513590701253511

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/17558683

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48591929&oldid=1231615976"